Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of separation science"
DOI: 10.1002/jssc.202200112
Abstract: Antibody-based therapeutic agents and other biopharmaceuticals are now used in the treatment of many diseases. However, when these biopharmaceuticals are administrated to patients, an immune reaction may occur that can reduce the drug's efficacy and…
read more here.
Keywords:
drug antibodies;
anti drug;
analysis;
detection analysis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "International Journal of Colorectal Disease"
DOI: 10.1007/s00384-021-03855-4
Abstract: Secondary loss of response (LOR) to infliximab (IFX) commonly occurs. One cause is the development of anti-drug antibodies (ADAs). Evidence regarding the optimal management of ADAs is lacking. We aim to identify the best practice…
read more here.
Keywords:
clinical outcomes;
ifx;
value;
management ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Pharmacokinetics and Pharmacodynamics"
DOI: 10.1007/s10928-025-09971-w
Abstract: The aim of the analysis was to develop a phenomenological longitudinal population pharmacokinetics (PK)-anti-drug antibodies (ADA) model to enable an informed and quantitative framework for assessment of ADA influence. Data used were from seven clinical…
read more here.
Keywords:
time;
drug antibodies;
anti drug;
drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Prevention Science"
DOI: 10.1007/s11121-017-0836-7
Abstract: For the current study, we developed and tested a biopsychological model to combine research on psychological tension, the Limited Capacity Model of Motivated Mediated Message Processing, and the endocrine system to predict and understand how…
read more here.
Keywords:
unpleasant information;
persuasive messages;
pleasant unpleasant;
biopsychological model ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Drugs"
DOI: 10.1007/s40265-021-01621-y
Abstract: Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by mutations in the α-galactosidase A (AGAL/GLA) gene. The lysosomal accumulation of the substrates globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) results in progressive renal failure,…
read more here.
Keywords:
enzyme replacement;
fabry disease;
disease;
neutralizing anti ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical immunology"
DOI: 10.1016/j.clim.2019.01.009
Abstract: In Pompe disease, anti-drug antibodies (ADA) to acid alpha-glucosidase (GAA) enzyme replacement therapy contribute to early mortality. Assessing individual risk for ADA development is notoriously difficult in (CRIM-positive) patients expressing endogenous GAA. The individualized T…
read more here.
Keywords:
antibodies ada;
risk;
risk developing;
drug antibodies ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Immunological Methods"
DOI: 10.1016/j.jim.2020.112736
Abstract: The recent identification of human monoclonal antibodies with broad and potent neutralizing activity against HIV-1 (bnAbs) has resulted in substantial efforts to develop these molecules for clinical use in the prevention and treatment of HIV-1…
read more here.
Keywords:
antibody;
anti drug;
hiv;
hiv bnabs ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2043546
Abstract: Abstract Background Biologics for psoriasis are registered in standard dosages. In patients with low disease activity, reduction of the dose by interval prolongation can prevent overtreatment, and lower risks and costs. However, fear for increased…
read more here.
Keywords:
anti drug;
adalimumab;
drug;
interval prolongation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2114288
Abstract: Abstract Biologics may elicit the production of anti-drug antibodies (ADAs), the clinical significance of which is not fully understood. ADA development in psoriasis patients on IL-17 inhibitors was evaluated by incidence, impact on efficacy, and…
read more here.
Keywords:
ixekizumab brodalumab;
drug antibodies;
anti drug;
antibodies inhibitors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Bioanalysis"
DOI: 10.1080/17576180.2024.2389637
Abstract: Aim: This study aims to compare the anti-drug antibody (ADA) interference in four pharmacokinetic (PK) assays across different platforms (AlphaLISA, Gyrolab, LC-MS/MS) and to devise a strategy for ADA interference mitigation to improve the accuracy…
read more here.
Keywords:
insulin;
drug antibodies;
anti drug;
drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Bioanalysis"
DOI: 10.1080/17576180.2024.2441058
Abstract: BACKGROUND Commonly, ligand-binding platforms are being used for immunogenicity assessment, but with the recent advent of liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) for protein quantification, this technology has become an alternative for the…
read more here.
Keywords:
isotyping semi;
drug antibodies;
anti drug;
drug ... See more keywords